Oral beta-adrenergic agonists in heart failure--a new therapeutic possibility?

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.

Atherosclerosis·2001

Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.

Thrombosis and haemostasis·2000

Heart rate variability and progression of coronary atherosclerosis.

Arteriosclerosis, thrombosis, and vascular biology·1999

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.

Circulation·1998

The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial.

Atherosclerosis·1998

Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

The Journal of clinical investigation·1998

Exercise prescription in medical practice.

Annals of clinical research·1988

More exercise for the hyperlipidaemic patients?

Annals of clinical research·1988

More exercise for the obese?

Annals of clinical research·1988

Physical activity and effects of muscle training in the elderly.

Annals of clinical research·1988

Physical activity in the prevention of ischaemic heart disease.

Annals of clinical research·1988

New methodologies for studying the prevention of atherosclerosis.

Annals of clinical research·1988

Regulatory roles of pyroptosis-associated lncRnas in breast cancer progression and immune microenvironment.

Cell cycle (Georgetown, Tex.)·2026

Insights Into the Mechanisms of Biological Aging That Guide Translational and Clinical Research.

Aging medicine (Milton (N.S.W))·2026

Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.

International journal of nanomedicine·2026

Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.

International journal of pharmaceutics: X·2026

Enhanced anticancer efficacy of Pa-MAP 1.9 peptide-coated silver nanostars on breast cancer cells.

Materials today. Bio·2026

Surface-engineered milk-derived extracellular vesicles enable oral miRNA therapy against immunosuppressive pancreatic cancer.

Materials today. Bio·2026

Related Experiment Videos

Oral beta-adrenergic agonists in heart failure--a new therapeutic possibility?

Related Concept Videos

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.

Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.

Heart rate variability and progression of coronary atherosclerosis.

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.

The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial.

Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

Exercise prescription in medical practice.

More exercise for the hyperlipidaemic patients?

More exercise for the obese?

Physical activity and effects of muscle training in the elderly.

Physical activity in the prevention of ischaemic heart disease.

New methodologies for studying the prevention of atherosclerosis.

Regulatory roles of pyroptosis-associated lncRnas in breast cancer progression and immune microenvironment.

Insights Into the Mechanisms of Biological Aging That Guide Translational and Clinical Research.

Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.

Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.

Enhanced anticancer efficacy of Pa-MAP 1.9 peptide-coated silver nanostars on breast cancer cells.

Surface-engineered milk-derived extracellular vesicles enable oral miRNA therapy against immunosuppressive pancreatic cancer.

Related Experiment Videos

Oral beta-adrenergic agonists in heart failure--a new therapeutic possibility?

Related Concept Videos

Related Articles